TEVA-LISDEXAMFETAMINE

Identification of Teva-Lisdexamfetamine

No description

Google image searchProduct monograph

Active ingredient

lisdexamfetamine dimesylate, 40 MG

DIN: 02545918

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Schedule G (CDSA I)

Company: TEVA CANADA LIMITED

Date: 03-JUN-2024

ATC:

Reference brand drug: Vyvanse

Search on Google

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find teva-lisdexamfetamine photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.